SEC 13F Intelligence

Achmea Investment Management B.V. / UTHR

Achmea Investment Management B.V.’s United Therapeutics Corp Del Position

Does Achmea Investment Management B.V. own United Therapeutics Corp Del (UTHR)? Yes21.9K shares worth $13M (+0.34% of its 13F portfolio) as of Q1 2026, up from 20.6K shares the prior filed quarter.

Position Value
$13M
Q1 2026
Shares
21.9K
% of Portfolio
+0.34%
Quarters Held
13
currently held

Position History UTHR

Reported value by quarter
Q1 ’19: $1MQ1 ’19Q2 ’19: $150,000Q1 ’20: $83,000Q1 ’20Q2 ’20: $106,000Q1 ’23: $1MQ1 ’23Q2 ’23: $1MQ3 ’24: $9MQ3 ’24Q4 ’24: $13MQ1 ’25: $18MQ1 ’25Q2 ’25: $11MQ3 ’25: $10MQ3 ’25Q4 ’25: $10MQ1 ’26: $13MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202621.9K$13M+0.34%
Q4 202520.6K$10M+0.26%
Q3 202524.1K$10M+0.13%
Q2 202537.8K$11M+0.14%
Q1 202559.2K$18M+0.27%
Q4 202436.7K$13M+0.21%
Q3 202424.1K$9M+0.14%
Q2 20234.8K$1M+0.02%
Q1 20234.9K$1M+0.03%
Q2 2020872$106,0000.00%
Q1 2020872$83,0000.00%
Q2 20191.9K$150,000+0.01%
Q1 201912.0K$1M+0.06%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Achmea Investment Management B.V.’s full portfolio or all institutional holders of UTHR.